CAS: 1675248-19-7
Tofacitinib Amide (3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide)
CAS:1675248-19-7
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, …
Formula:
C16H22N6O2
Color and Shape:
White Off-White Solid
Molecular weight:
330.18042
Estimated delivery in United States, on Friday 3 Jan 2025
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
CAS:1675248-19-7
Formula:
C16H22N6O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
330.3849
Ref: IN-DA00ABHG
10mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Tofacitinib Impurity 61
CAS:1675248-19-7
Formula:
C16H22N6O2
Color and Shape:
White To Off-White Solid
Molecular weight:
330.39
Ref: 4Z-T-117025
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Tofacitinib impurity L
Controlled ProductCAS:1675248-19-7
Impurity Tofacitinib Impurity (T528000) Applications Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an …
Formula:
C16H22N6O2
Color and Shape:
Neat
Molecular weight:
330.38
Ref: TR-T528015
10mg | 1,091.00 € | ||
25mg | 1,954.00 € | ||
2500µg | 296.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
CAS:1675248-19-7
Purity:
98%
Molecular weight:
330.3919982910156
Ref: 10-F789597
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Tofacitinib impurity L
CAS:1675248-19-7
Please enquire for more information about Tofacitinib impurity L including the price, delivery time and …
Formula:
C16H22N6O2
Purity:
Min. 95%
Molecular weight:
330.38 g/mol
Ref: 3D-ASC24819
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025